Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Swedish Orphan Biovit Ord (BIOVF)

Swedish Orphan Biovit Ord (BIOVF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Swedish Orphan Biovit Ord Tomtebodavagen 23 A Solna Stockholm V7 SE-112 76 SWE

P: 46-8697-2000

Description:

Swedish Orphan Biovitrum is a biotechnology company. It develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company's product portfolio consists of Core Products segment which offers pharmaceuticals within Inflammation area and Genetics and metabolic therapeutic area; Partner Products segment which offers pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The company operates primarily in Sweden, Denmark, Finland, Norway, United Kingdom and France. Swedish Orphan Biovitrum is based in Solna, Sweden.

Key Statistics

Overview:

Market Capitalization, $K 6,997,034
Enterprise Value, $K 6,997,957
Shares Outstanding, K 299,980
Annual Sales, $ 1,811 M
Annual Net Income, $ 312,370 K
Last Quarter Sales, $ 393,800 K
Last Quarter Net Income, $ 26,210 K
60-Month Beta 0.39
% of Institutional Shareholders 0.00%
Float, K 299,980
% Float 100.00%
Short Volume Ratio 1.00

Growth:

1-Year Return 20.98%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.09 on 07/19/22
Next Earnings Date N/A
Earnings Per Share ttm 1.13
EPS Growth vs. Prev Qtr -76.92%
EPS Growth vs. Prev Year -18.18%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BIOVF Ratios

Ratio
Price/Earnings ttm 19.91
Price/Earnings forward 24.73
Price/Earnings to Growth N/A
Return-on-Equity % 13.21%
Return-on-Assets % 6.37%
Profit Margin % 17.25
Net Margin % N/A
Debt/Equity 0.35
Price/Sales 3.66
Price/Cash Flow 12.36
Price/Book 2.73
Book Value/Share 8.24
Interest Coverage 8.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar